Short Gut Syndrome Patient, Family & Professional Support Groups

Q: Is the prognosis for short bowel syndrome as bad as the doctors make it sound?

Short bowel syndrome (SBS) is a rare condition that affects only an estimated 10,000-20,000 people in the United States. 1 This means that many doctors have seen few, if any, patients with SBS in their careers.

Most knowledge about SBS comes from journal articles and interactions with a handful of patients. In the fast-changing world of medicine, that creates an opportunity for out-of-date knowledge.

Short bowel syndrome can have serious health consequences. Unless the intestine adapts, patients can't take in enough nutrition and hydration, so they rely on nutrition support, often in an intravenous form called TPN. Long-term TPN puts patients at risk of blood infections and liver damage. However, treatment options have changed dramatically over the past 50 years. 2

While previously outcomes were poor, care has evolved so that long-term life expectancy is typical, even for patients with little bowel remaining. 3 Successful medical and surgical treatment options are available. There are better ways to manage TPN and its complications. New treatments and medicines are available, and others are on the horizon. With time and treatment from a qualified medical team, many patients reduce or eliminate the need for TPN and tube feeding. 4 The majority of patients receive treatment at home. 2 Although adjustments and precautions are needed to live with their disease, short bowel syndrome can become a part of normal life.

It is difficult to measure the outcomes for short bowel syndrome based on past data because care is constantly improving. The future of SBS care is filled with hope.


References

  1. According to a 2023 Market share study, there were 14,000 affected people in the United States
    Short Bowel Syndrome - epidemiology forecast - 2034. Research and Markets Ltd 2024. Retrieved March 2, 2024, from https://www.researchandmarkets.com/reports/5345917/short-bowel-syndrome-epidemiology-forecast
  2. Cohran VC, Prozialeck JD, Cole CR. Redefining short bowel syndrome in the 21st century. Pediatr Res. 2017 Apr;81(4):540-549. doi: 10.1038/pr.2016.265. Epub 2016 Dec 20. PMID: 27997531.
  3. Wendel D, Javid PJ. Medical and Surgical Aspects of Intestinal Failure in the Child. Surg Clin North Am. 2022 Oct;102(5):861-872. doi: 10.1016/j.suc.2022.07.015. Epub 2022 Sep 13. PMID: 36209751.
  4. DiBaise, J. K., Iyer, K., & Rubio–Tapia, A. (2022). AGA Clinical Practice Update on Management of Short Bowel Syndrome: Expert Review. Clinical Gastroenterology and Hepatology, 20(10), 2185-2194.e2. https://doi.org/10.1016/j.cgh.2022.05.032
  5. Neumann ML, Allen JY, Kakani S, Ladner A, Rauen MH, Weaver MS, Mercer DF. A beautiful struggle: Parent-perceived impact of short bowel syndrome on child and family wellbeing. J Pediatr Surg. 2022 Sep;57(9):149-157. doi: 10.1016/j.jpedsurg.2021.09.039. Epub 2021 Oct 1. PMID: 34702565.





This website is created by families for families. This site does not provide medical or any other health advice, diagnosis, and/or treatment. This site and its services, including the information above, are for informational purposes only and are not a supstitute for professional medical or health advice, examination, diagnosis, and treatment. Always seek the advice of your physician or other health care provider before starting any new treatment, making any changes to existing treatment, or altering in any way your or your child's current care or diet regimen. Do not delay seeking or disregard medical advice based on the information on this site. Some of the information on this site may be incorrect or out of date. No health information on this site is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure, or prevent any disease without the supervision of a medical professional.